HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11304997
APP PUB NO 20200121772A1
SERIAL NO

16715758

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 15 and consisting of 11 or less amino acid residues.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEC CORPORATION7-1 SHIBA 5-CHOME MINATO-KU TOKYO 108-8001

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hazama, Shoichi Yamaguchi, JP 13 5
Miyakawa, Tomoya Tokyo, JP 26 45
Oka, Masaaki Yamaguchi, JP 91 1320
Tamada, Koji Yamaguchi, JP 45 171
Udaka, Keiko Kochi, JP 22 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 19, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 19, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 19, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00